Stem cells from newborn umbilical cord blood + cord tissue are a treasure that can potentially save your baby or family member who may need a lifesaving treatment. Cord blood and cord tissue are only available immediately after birth. Industry research has confirmed that cord blood stem cells remain viable after 30 years of cryopreservation. Cord for Life has been successfully storing highly functional stem cells for 27 years and counting. The process to collect your newborn’s stem cells is a simple and painless part of the delivery process.
If you’re thinking about cord blood + cord tissue banking, our Information Guide can help you get started. It answers questions about what cord blood and cord tissue are, what they can be used for, how cord blood + cord tissue banking works, and how to choose a cord blood + cord tissue bank. We share expert advice on what really matters so you can make an informed decision.
Trying to figure out which cord blood + cord tissue bank will give you the most stem cells, the safest transplants, and the highest product quality guarantee? Not sure which cord blood + cord tissue bank has the best value? Our side-by-side comparison of the top cord blood + cord tissue banks helps sort out the options.
Ready to sign-up for cord blood + cord tissue banking? Be sure to get your Collection Kit in time to bring it with you when you go into labor. Your OBGYN or midwife will need the kit to take advantage of this once in a lifetime opportunity to preserve your newborn’s cord blood + cord tissue. You can enroll easily on-line or call our team of cord blood + cord tissue specialists at +1-800-869-8608.
When developing PREMIERMAX®, we looked at four things: quality, safety, flexibility, and cost – the same things every parent should consider when choosing a cord blood + cord tissue bank. We chose the processing method that an unbiased team of researchers concluded was the best performer over the whole range of analysis.
We operate to the highest standards in the industry. As both a public and private cord blood + cord tissue bank, we’ve released more stem cells for transplant, clinical trials, and research than any private cord blood bank. Knowing how important each unit is for the outcome of patients and the future of medicine, we take our obligations for quality control seriously.
We stand behind our products 100% and back our commitment with the highest Quality Guarantee in the cord blood + cord tissue banking industry. Our goal is to ensure a successful outcome for your child or other family member in need of a stem cell transplant.
We believe in the power of stem cells and want to help families dealing with a loved one suffering from a life threatening illness. If you are currently pregnant and have another child or family member that has been diagnosed with a disease treatable by stem cell transplant, you may be eligible.
Thank you for taking the time to learn more about the potential of stem cells from your newborn’s umbilical cord blood. We want to help families make the most informed decision about their stem cells banking choices. We offer both private and public cord blood banking services to meet the needs of our clients and the general public.
At Cord for Life®, we believe in the power of stem cells. Since our founding, we’ve been involved in over 2,200 cord blood transplants. We’re inspired each time by the families and medical professionals we’ve helped use cord blood stem cells to treat their loved ones.
Having been a part of such an important treatment opportunity for so many families, we feel an obligation to get the most from every stem cell collection. We know that the ultimate measure of success is a healthy patient, and we want to be sure we do everything possible to ensure each family gets the best results.
We focus on what matters – getting as many stem cells as possible, ensuring the highest quality, and giving parents the highest level of support.
We are here to answer any questions you have and hope that you will consider Cord for Life® for your cord blood banking needs.
Sincerely,
Syed Raheel
President, Cord for Life®
What is a 5-compartment cord blood freezer bag? Historically, cord blood was stored in a cryo-bag with only one or two chambers. Using a one chamber bag requires all of the stored product to be used at one time. A two-chamber bag typically has 80% in one section and 20% in the other section and […]
Cord for Life® ANNOUNCES CORD BLOOD CLINICAL TRIAL Phase I Trial for the Treatment of lower back pain of the Sacroiliac Joint ALTAMONTE SPRINGS, FL (October 29, 2021) Cord for Life®, a full-service cord blood bank with over 25 years of experience, today announced plans to conduct a clinical trial to treat lower back pain arising from the Sacroiliac Joint (SIJ) using a biological therapeutic derived from umbilical cord blood. The company has received […]
The results of a Phase I study published in Stem Cell Translational Medicine suggest that it is safe and feasible to infuse stem cells from banked umbilical cord blood into adults following an acute ischemic stroke. This research paves the way for additional studies into the efficacy of umbilical cord blood in treating stroke patients. […]
I have stored all five of my children’s cord blood. I love the reassurance of knowing that all five of my children have their stem cells and all five are stored together at the same facility. My children may never need it but, their stem cells are there if they do. It’s like having life insurance policy, we most likely will never need it, but it’s reassuring that it’s there in case we do.
The ultimate measure of our success is a healthy patient.
Reserve your Cord Blood Collection Kit in time to bring it with you when you go into labor. Give your newborn every advantage with cord blood banking!
By donating your newborn’s cord blood, you are joining a nationwide effort to create a genetically diverse inventory of stem cells for transplant to a child.
Mr. Kondorosi has been involved with the hospitality and hotel industry for most of his life. From 1969 through 1985, he held various positions at the international InterContinental Hotels chain, including various senior management roles. After his transitioning to the USA, he moved into the real estate business and held a variety of positions. Recently he has held te position of Director of Sales for Prestige Homes, Inc. part of Goldrich and Kest Industries headquartered in California since 1957. Mr. Kondorosi represented the successful sale of 386 homes in the Bel Air Crest Development, including re-sales over the past several years, various high end listings and sales in prominent locations such as Malibu, Pacific Palisades, Bel Air, Beverly Hills and other parts of the west-side Los Angeles area.
Mr. Kondorosi is also the founder and President of EDKO Trade, Inc., and international real estate and trading company involved in promoting and closing transactions between various companies and individuals located around the world. Since 2000, he has also been involved in various international and foreign innovative startup companies in various capacities including CEO, board member or in a consulting role. Mr. Kondorosi received a Juri Doctor degree from Janus Pannonius University in Hungary in international law. He also was a professor at the Budapest Business School / Faculty of Commerce, Catering and Tourism in Hungary.
In addition, Mr Kondorosi has served on the Board for the Regency Club from 2008 through 2011, a private business organization started by David Murdock 30 years ago in Los Angeles.
Dr. Parkhill directs operations at the Sanofi Pasteur VaxDesign Campus, which designs, develops, and manufactures in vitro models of the human immune system. Their mission is to prevent infectious disease by forecasting vaccine responses before clinical trials, and create a competitive advantage by providing predictive in vitro immunological models and assays.
Dr. Parkhill holds a PhD in Material Science and Inorganic Chemistry for Oklahoma State University.
Don joined Sanofi Pasteur VaxDesign in 2005 and has served as Director of Immunological Research since 2009. He has had a long-standing interest in the immune system, particularly the interaction between viruses and elements of the adaptive immune system, since initiating his graduate studies at Emory University in Atlanta, GA.
As a post-doctoral fellow at the University of Virginia, he was awarded funding from the Cancer Research Institute and received an Interdisciplinary Training Grant in Immunology from the National Institutes of Health to study CD8+ T cell immunity against influenza virus.
At VaxDesign, Don leads a team developing and optimizing the MIMIC® System to permit the evaluation of human adaptive immunity (cellular and humoral responses) against vaccine candidates, biologics, and other immunomodulators in a pre-clinical setting. He is an author on a variety of patents and peer-reviewed journal publications.
Dr. Pollock was originally from Ohio where he majored in pharmacy at Ohio Northern University. After graduation he worked as a pharmacist and attended The Ohio State University where he majored in chemistry and graduated in biochemistry.
In 1992 he attended Wright State University School of Medicine in Dayton Ohio, after graduating from medical school he completed his residency at Orlando Regional Medical Center in anatomic and clinical pathology, then a two year fellowship in clinical molecular genetics at All Children’s Hospital in St Petersburg Florida. After completing his fellowship in genetics, he became Medical Director for Central Florida Blood Bank for 3 years where he took great interest in the stem cell donation program.
After leaving the blood bank, Dr Pollock became Assistant Director in Molecular Genetics for the Centers of Advanced Diagnostics which at the time was a division of Ameripath. After the restructuring of the Orlando operation, Dr Pollock found himself back in blood banking. He was medical director for BloodNetUSA in Lakeland, Florida prior to its merger with Florida Blood Services.
Dr. Tisha M. Foster joined Florida’s Blood Centers (FBC) in 2008 and is responsible for therapeutic apheresis, cellular therapies, and FBC’s participation in the National Marrow Donor Program.
She received her undergraduate degree from the University of Central Oklahoma and her medical degree from the University of Oklahoma. She completed her residency at the University of Oklahoma Health Sciences Center and her fellowship at the Medical College of Wisconsin/Blood Center of Wisconsin.
Prior to joining FBC, Dr. Foster served as medical director at BloodNetUSA in Lakeland (Fla.), where her responsibilities included supervision of the Transfusion Service Laboratory at Lakeland Regional Medical Center, donor eligibility, therapeutic apheresis, and ensuring regulatory compliance throughout the blood center.
Dr. Richard R. Gammon joined Florida’s Blood Centers (FBC) in 2005 and is responsible for ensuring that the organization’s medical practices, policies and testing remain at the forefront of the blood-banking industry. He received his undergraduate degree from Gannon University in Erie, Pennsylvania and medical degree from Hahnemann University in Philadelphia.
He completed his residency at The Ohio State University and his fellowship at the University of Virginia. He also serves as an assistant professor of pathology at the University of Central Florida College of Medicine. He has served as President and Technical Committee Chair of the Florida Association of Blood Banks. He currently serves as the Chair of the Scientific Medical and Technical Committee and Chair of the Journal Club for America’s Blood Centers.
He is an assessor and abstract reviewer for AABB and is a manuscript reviewer for the journal Transfusion. He is the co-recipient of a 2011 ABC Foundation Grant for the Get Healthy Wellness Program. Dr. Gammon’s research has been published in various peer-reviewed journals and he has been a featured speaker at numerous national and international conferences on blood banking and transfusion medicine.
Ms. Sardone has over 30 years of clinical laboratory experience as a Clinical Laboratory Technologist and Supervisor, including over 25 years with Central Florida Regional Hospital (CFRH). She was Supervisor of Quality Assurance, Safety and Education at CFRH for 11 years, held the positions of Blood Bank Supervisor for 11 years, and Hematology Supervisor for 1 year. She has participated in both sides of the inspection process, serving on the College of American Pathologists Inspection team for CAP Hospital Accreditation in Florida, and assisting in receiving accreditation by The Joint Commission (TJC), American Association of Blood Banks (AABB), and Food and Drug Administration (FDA) through the inspections of the clinical laboratory. Ms. Sardone is licensed by the State of Florida as a Clinical Laboratory Technologist in Immunohematology, Hematology, Serology and Clinical Chemistry. She is a certified Clinical Laboratory Technologist with the American Society of Clinical Pathologists (ASCP). Ms. Sardone serves as Manager of Quality Assurance and Regulatory Affairs at Cord For Life, Inc. overseeing all licensing and regulatory agencies to ensure that the highest quality in all aspects of cord blood collection, processing, and storage is maintained. Ms. Sardone has been with Cord For Life for over 5 years of dedicated service. Her skills and knowledge in blood banking and quality assurance have enabled her to establish, implement and maintain a superior quality system that meets and exceeds all standards and regulatory requirements for Cord For Life, Inc.
Personal Background:
Ms. Cable has 35+ years – experience in Office, Management, Human Resources, & Customer Service. As the Director of Administration and Client Services, Ms. Cable joined Cord for Life in December 2006, and has assisted in providing more efficient and effective ways to ease the enrollment process, as well as obtaining and establishing excellent customer care during the enrollment and donation period; for our Storage and Donation customers.
Personal Background:
Mr. Hudspeth has over 28 years of clinical laboratory experience as a certified Medical Technologist (ASCP), including ten years with the University of North Carolina Hospitals and 18 years with Cord for Life. Mr. Hudspeth is licensed by the State of Florida as a Clinical Laboratory Supervisor in Immunohematology, Hematology, Serology, Clinical Chemistry, Molecular Pathology and Microbiology as well as a Clinical Laboratory Scientist and has completed the AABB Certification in Cellular Therapies through George Washington University.
Mr. Hudspeth is a registered Technologist with the American Society of Clinical Pathologists and a member of the Cord Blood Association. He has also enjoyed teaching Immunology to Clinical Laboratory Science and medical school students at UNC while working in the UNCH clinical labs. Mr. Hudspeth is an Eagle Scout with 5 palms and has served numerous volunteer positions within the local Scouts BSA Troop and Pack.
Personal Background:
During the last two years of Medical School, Dr. Irrgang was in the United States Navy 1915 Ensign Program and completed a clerkship at the Naval Hospital at Charleston, South Carolina as well as a research clerkship at the Naval Aerospace Institute at Pensacola, Florida. Dr. Irrgang completed her four year Pathology residency at Baylor University Medical Center, and her internship at the University District Hospital, Rio Piedras in San Juan, Puerto Rico.
Currently, Dr. Irrgang is Board Certified in Anatomic and Clinical Pathology and licensed in the states of South Carolina, Texas, New Jersey and Florida and she is an Associate Medical Examiner at the District Nine Medical Examiners Office. Dr. Irrgang is a fellow at numerous organizations including; The College of American Pathologists, National Association of Medical Examiners, Florida Association of Medical Examiners, Seminole County Medical Society, and the Florida Medical Society.